Robotic Gamma Probe Detects Cancer Intra-Operatively
|
By MedImaging International staff writers Posted on 27 Jan 2021 |

Image: The Sensei Robotic Gamma Probe (Photo courtesy of Lightpoint Medical)
A novel intra-operative probe detects sentinel lymph node (SLN) and other cancer metastases through the lymphatic system.
The Lightpoint Medical (Chesham, United Kingdom) Sensei is a tethered gamma probe designed to be used as a guide during laparoscopic biopsy procedures. The probe locates single-photon emission computed tomography (SPECT) radioligands, such as 99mTc-nanocolloid for SNL metastasis detection, or for targeted cancer metastasis antigens, such as 99mTc-PSMA (prostate specific membrane antigen) during prostate cancer surgery. The single-use, disposable probe measures just over 40mm and is attached to a three meter long lightweight cable, supporting both intra-cavity manual and robotic laparoscopic procedures.
When used with articulating graspers, the probe can provide up to six degrees of freedom, allowing for complete intra-cavity maneuverability and dexterity. The system provides clear audible notifications and is also equipped with a graphic display. It can also be integrated with the display of any surgical robotic platform. And as it is disposable, there is no need for a sterile sheath or reprocessing, eliminating the risk of cross-contamination. At the end of the procedure, the probe can be easily extracted through a standard 12mm entry port for disposal.
“Lightpoint is developing the most advanced intra-operative cancer detection technologies to meet surgeons' needs for miniaturized cancer detection tools,” said David Tuch, CEO of Lightpoint Medical. “Currently, surgeons have no way to precisely detect cancer intra-operatively. As a result, millions of patients suffer every year as cancer is frequently left behind or healthy, functional tissue is needlessly removed.”
Lymph nodes, located throughout the body, serve as biologic filters that contain immune cells to fight infection and clean the blood. When cancer cells break away from a tumor, the cells can travel through the lymph system, and SNLs help determine cancer spread. But human SNLs are only half a centimeter in size, and are difficult to discern among the surrounding tissue during surgery. Furthermore, even when surgeons are able to map the location of the nodes, there is no current technique that indicates whether or not the lymph nodes contain cancer, requiring their removal.
Related Links:
Lightpoint Medical
The Lightpoint Medical (Chesham, United Kingdom) Sensei is a tethered gamma probe designed to be used as a guide during laparoscopic biopsy procedures. The probe locates single-photon emission computed tomography (SPECT) radioligands, such as 99mTc-nanocolloid for SNL metastasis detection, or for targeted cancer metastasis antigens, such as 99mTc-PSMA (prostate specific membrane antigen) during prostate cancer surgery. The single-use, disposable probe measures just over 40mm and is attached to a three meter long lightweight cable, supporting both intra-cavity manual and robotic laparoscopic procedures.
When used with articulating graspers, the probe can provide up to six degrees of freedom, allowing for complete intra-cavity maneuverability and dexterity. The system provides clear audible notifications and is also equipped with a graphic display. It can also be integrated with the display of any surgical robotic platform. And as it is disposable, there is no need for a sterile sheath or reprocessing, eliminating the risk of cross-contamination. At the end of the procedure, the probe can be easily extracted through a standard 12mm entry port for disposal.
“Lightpoint is developing the most advanced intra-operative cancer detection technologies to meet surgeons' needs for miniaturized cancer detection tools,” said David Tuch, CEO of Lightpoint Medical. “Currently, surgeons have no way to precisely detect cancer intra-operatively. As a result, millions of patients suffer every year as cancer is frequently left behind or healthy, functional tissue is needlessly removed.”
Lymph nodes, located throughout the body, serve as biologic filters that contain immune cells to fight infection and clean the blood. When cancer cells break away from a tumor, the cells can travel through the lymph system, and SNLs help determine cancer spread. But human SNLs are only half a centimeter in size, and are difficult to discern among the surrounding tissue during surgery. Furthermore, even when surgeons are able to map the location of the nodes, there is no current technique that indicates whether or not the lymph nodes contain cancer, requiring their removal.
Related Links:
Lightpoint Medical
Latest Nuclear Medicine News
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
Channels
Radiography
view channel
New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
X-ray imaging offers limited visualization of soft tissues like cartilage, complicating evaluation of joint pain and degenerative disease. Clinicians often rely on joint-space narrowing as a proxy for... Read more
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read moreMRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
Hybrid AI System Improves Early Lung Cancer Detection on CT
Early lung cancer often presents as tiny nodules on computed tomography (CT) that are difficult to distinguish from normal tissue, leading to delayed diagnoses. Missed or late findings limit timely intervention... Read more
Radiomics Analysis of CT Scans Enhances Evaluation of Sarcoidosis
Sarcoidosis is a complex inflammatory lung disease that can cause scarring and breathing difficulties in more than 150,000 people in the United States. Clinicians often rely on visual review of chest computed... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







